Soricimed Biopharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
18 Botsford St Ste 201, Moncton, New Bru...Phone Number
(506) 856-0400Website
www.soricimed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Soricimed Biopharma
Soricimed is a private oncology-focused company that specializes in developing precision therapies for the treatment of solid tumor cancers. They utilize proprietary TRPV6 peptide ligands to create targeted radioligand therapies and peptide-drug conjugates, which deliver radioisotopes directly to cancer cells. Their innovative approach targets the TRPV6 calcium channel, which is overexpressed in certain solid tumor cancer cells, aiding in growth and resistance to cell death. Soricimed is actively seeking partnerships and research collaborations to advance their drug development programs.Explore more
Soricimed Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Soricimed Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Soricimed Biopharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Soricimed Biopharma has new funding data
Check if Soricimed Biopharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Soricimed Biopharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Soricimed Biopharma
Earning: See what the market has to say on Soricimed Biopharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Soricimed Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Soricimed Biopharma launches new products
Recommended Actions
Find VP level buyers at Soricimed Biopharma
Find 3 more new buyers
Compare Similar Companies to Soricimed Biopharma
Compare insights from companies similar to Soricimed Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Soricimed Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Soricimed Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Soricimed Biopharma.
Soricimed Biopharma Tech Stack
A closer look at the technologies used by Soricimed Biopharma
See more technologies
Soricimed Biopharma News & Media
Soricimed Appoints Frank Michalargias as Chief Financial Officer - Newswire.CA
/CNW/ - Soricimed Biopharma Inc., (Soricimed) has appointed Frank Michalargias as Chief Financial Officer (CFO). Soricimed, based in Moncton, NB, is a clinical...Soricimed Publishes New Research Validating TRPV6 as a Therapeutic Target for Ovarian Cancer
MONCTON, New Brunswick, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce the peer reviewed publication of new results from its anti-cancer research program in the Journal of Cancer.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Soricimed Biopharma
Sign Up For FreeTo access detailed company insights
Soricimed is a private oncology-focused company that specializes in developing precision therapies for the treatment of solid tumor cancers. They utilize proprietary TRPV6 peptide ligands to create targeted radioligand therapies and peptide-drug conjugates, which deliver radioisotopes directly to cancer cells. Their innovative approach targets the... Read More
